Rothschild Investment LLC Arcutis Biotherapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.44 Trillion
- Q2 2024
A detailed history of Rothschild Investment LLC transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 60 shares of ARQT stock, worth $608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$608% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ARQT
# of Institutions
193Shares Held
127MCall Options Held
5.43MPut Options Held
257K-
Jennison Associates LLC11.6MShares$117 Million0.07% of portfolio
-
Suvretta Capital Management, LLC New York, NY10MShares$101 Million3.89% of portfolio
-
Rubric Capital Management LP New York, NY9.82MShares$99.5 Million2.7% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$89.1 Million4.82% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$87.4 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $610M
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...